These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 583218)

  • 21. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verapamil cardioplegia: improved myocardial preservation during global ischemia.
    Balderman SC; Chan AK; Gage AA
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):57-66. PubMed ID: 6738103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of diltiazem, verapamil, nifedipine, and nicardipine on sympathetic tachycardia in decentralized hearts of anesthetized dogs.
    Satoh E; Mukaiyama O; Kimura T; Satoh S
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):661-6. PubMed ID: 1706810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of verapamil and its combination with glucose-insulin-potassium-infusion on acute myocardial ischemia in dogs.
    Goos H; Pissarek M; Nöhring J; Graff J; Buller G; Lindenau KF; Beyerdörfer I; Krause EG
    Biomed Biochim Acta; 1987; 46(8-9):S597-601. PubMed ID: 3325047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor.
    Eddy LJ; Oei HH; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
    Nakaya H; Kanno M
    Arzneimittelforschung; 1982; 32(6):626-9. PubMed ID: 7202368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reperfusion injury in ischemic myocardium: effects of nifedipine and verapamil.
    Mrak RE; Carry MM; Murphy ML; Peng CF; Straub KD
    Am J Cardiovasc Pathol; 1990; 3(1):61-8. PubMed ID: 2331362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neural factor involved in increase of the glycogen phosphorylase activity after coronary ligation in both ischemic and nonischemic areas of the dog heart.
    Sakai K; Abiko Y
    Circ Res; 1982 Dec; 51(6):733-42. PubMed ID: 6128082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of isoproterenol on the metabolism of normal and ischemic heart.
    Andrieu JL; Vial C; Font B; Goldschmidt D; Ollagnier M; Faucon G
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):255-69. PubMed ID: 7406584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dipyridamole on the glycogen metabolism in the normal and ischemic canine myocardium.
    Ichihara K; Abiko Y
    Experientia; 1975 Oct; 31(10):1198-9. PubMed ID: 1204739
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of calcium-antagonistic coronary vasodilators, nifedipine and verapamil, on ventricular automaticity of the dog.
    Endoh M; Yanagisawa T; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):235-8. PubMed ID: 652065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting effects of nifedipine and verapamil on myocardium and vascular smooth muscle at two levels of coronary occlusion in the dog.
    Weintraub WS; Hattori S; Agarwal JB; Bodenheimer MM; Banka VS; Helfant RH
    Am Heart J; 1983 Dec; 106(6):1347-52. PubMed ID: 6650356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of flunarizine on ischemic myocardial metabolism in dogs.
    Ichihara K; Maie S; Abiko Y
    Eur J Pharmacol; 1989 Jun; 165(1):19-27. PubMed ID: 2767133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute changes of myocardial norepinephrine and glycogen phosphorylase in ischemic and non-ischemic areas after coronary ligation in dogs.
    Sakai K; Abiko Y
    Jpn Circ J; 1981 Nov; 45(11):1250-5. PubMed ID: 7300006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crossover plot study of glycolytic intermediates in the ischemic canine heart.
    Ichihara K; Abiko Y
    Jpn Heart J; 1982 Sep; 23(5):817-28. PubMed ID: 6217359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ouabain on myocardial metabolic and contractile responses to coronary ligation.
    Abiko Y; Ichihara K
    Eur J Pharmacol; 1978 Jan; 47(1):87-94. PubMed ID: 618733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nifedipine on creatine kinase release during myocardial ischemia in dogs.
    Welman E; Carroll BJ; Lawson JS; Selwyn AP; Fox KM
    Eur J Cardiol; 1978 Jul; 7(5-6):379-89. PubMed ID: 699937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nifedipine, a potent calcium-antagonistic coronary vasodilator, on atrioventricular conduction and blood flow in the isolated atrioventricular node preparation of the dog.
    Taira N; Narimatsu A
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(1):107-12. PubMed ID: 1178066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart.
    Yoshida R; Ichihara K; Abiko Y
    Jpn J Pharmacol; 1990 Aug; 53(4):435-41. PubMed ID: 1976843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.